1. Home
  2. CHRD vs RDY Comparison

CHRD vs RDY Comparison

Compare CHRD & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chord Energy Corporation

CHRD

Chord Energy Corporation

SELL

Current Price

$145.79

Market Cap

8.4B

Sector

Energy

ML Signal

SELL

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

SELL

Current Price

$14.85

Market Cap

9.9B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CHRD
RDY
Founded
2007
1984
Country
United States
India
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
9.9B
IPO Year
2010
2001

Fundamental Metrics

Financial Performance
Metric
CHRD
RDY
Price
$145.79
$14.85
Analyst Decision
Buy
Buy
Analyst Count
18
5
Target Price
★ $182.75
$14.79
AVG Volume (30 Days)
769.9K
★ 2.5M
Earning Date
11-04-2026
10-23-2026
Dividend Yield
★ 3.54%
0.44%
EPS Growth
N/A
★ N/A
EPS
★ 14.47
N/A
Revenue
N/A
N/A
Revenue This Year
$53.11
$4.58
Revenue Next Year
N/A
$11.95
P/E Ratio
★ $10.15
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$87.35
$11.36
52 Week High
$159.96
$15.67

Technical Indicators

Market Signals
Indicator
CHRD
RDY
Relative Strength Index (RSI) 50.91 70.24
Support Level $130.54 $12.91
Resistance Level $152.12 $15.08
Average True Range (ATR) 5.62 0.24
MACD 0.19 -0.02
Stochastic Oscillator 56.81 79.13

Price Performance

Historical Comparison
CHRD
RDY

About CHRD Chord Energy Corporation

Chord Energy Corp is an independent exploration and production (E&P) company engaged in the acquisition, exploration, development and production of crude oil, NGL and natural gas prominently in the Williston Basin, with limited non-operated interests in the Marcellus Shale. It operates in one reportable business segment, which is the E&P of crude oil, NGL and natural gas. The company derives revenue from the sale of crude oil, NGL and natural gas production.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: